SCHEMBL27440444

SCHEMBL27440444

COc1cc(Cl)nc(N2CCC(C)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.44
▸ MAPT P10636 7/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ HTT P42858 3/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ GAA P10253 3/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16035866 0.80 CYP1A2 (0.56) MAPTSMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL26695772 0.79 LMNA (0.60) LMNASMN1; SMN2HTTCYP1A2CYP3A4
SCHEMBL26695699 0.79 LMNA (0.48) LMNAMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL29998765 0.79 LMNA (0.51) LMNAMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL27440338 0.78 ALDH1A1 (0.49) LMNAMAPTSMN1; SMN2HTTKDM4E
SCHEMBL10143570 0.77 GALR2 (0.53) MAPTSMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL27449378 0.75 SUV39H2 (0.53) LMNA
SCHEMBL16701665 0.75 LMNA (0.63) LMNAMAPTSMN1; SMN2HTTCYP1A2
SCHEMBL24851307 0.73 CASP1 (0.49) LMNASMN1; SMN2HTTGAAL3MBTL1
SCHEMBL3536632 0.71 KMT2A (0.71) LMNAMAPTHTTCYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF KDM1A, TET1, KDM3A LMNA 1527/4885MAPT 138/4885SMN1; SMN2 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback